Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1Phase 2 Interventional Results available

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

ClinicalTrials.gov ID: NCT00790842

Public ClinicalTrials.gov record NCT00790842. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 3:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of the Tolerability of Lenalidomide and Low Dose Dexamethasone in Previously Treated Multiple Myeloma Patients With Impaired Renal Function

Study identification

NCT ID
NCT00790842
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
PrECOG, LLC.
Other
Enrollment
63 participants

Conditions and interventions

Interventions

  • Anticoagulants Drug
  • Dexamethasone Drug
  • Lenalidomide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 20, 2009
Primary completion
Sep 29, 2017
Completion
Mar 7, 2018
Last update posted
Oct 23, 2018

2009 – 2018

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Mayo Clinic in Arizona Scottsdale Arizona 85259-5499
Emory University Winship Cancer Atlanta Georgia 30322
University of IL at Chicago Chicago Illinois 60612
McFarland Clinic Ames Iowa 50010
Siouxland Hematology Oncology Associates Sioux City Iowa 51101
Michigan Cancer Research Consortium and Oncology Research- St. Joseph Mercy Hospital - Ann Arbor Ann Arbor Michigan 48106-0955
Mayo Clinic Rochester Minnesota 55905
Metro MN CCOP Saint Louis Park Minnesota 55416
Missouri Valley Cancer Consortium Omaha Nebraska 68106
Kinston Medical Specialists Kinston North Carolina 28501
University of Pennsylvania Philadelphia Pennsylvania 19104-4283
Reading Hospital and Medical Center West Reading Pennsylvania 19611
WVU Mary Babb Randolph Cancer Center Morgantown West Virginia 26506
Gundersen Lutheran La Crosse Wisconsin 54601
Waukesha Memorial Hospital (ProHealth Care) Waukesha Wisconsin 53188
Aurora Cancer Center Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00790842, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2018 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00790842 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →